Cancilico Raises €2.5M to Scale AI-Powered Bone Marrow Diagnostics

“We are facing a global shortage of hematologists, yet the complexity of diagnostic cases is rising”

26-Jan-2026 - Cancilico, an AI diagnostics startup specializing in blood cancer, announced the successful closing of its €2.5 million Seed financing round. The investment was led by a strong consortium including High-Tech Gründerfonds (HTGF), TGFS – Technologiegründerfonds Sachsen, GEDAD GmbH (investment ...

Health tech startup Carelane sets new standards for clinical research with AI-driven, end-to-end platform

Seed funding of EUR 2.6 million led by Vorwerk Ventures

07-Jul-2025 - As clinical studies are always increasing in complexity, research institutions’ software solutions remain fragmented and outdated. Carelane has developed an end-to-end platform that integrates all phases of a study, from protocol development to data analysis. Their innovative approach combines ...

Start-up wants to decarbonise the wastewater sector - with advanced sensor technology and AI

Variolytics Secures Growth Financing Round with Nordic Alpha Partners

03-Feb-2025 - Variolytics is delighted to announce the successful closure of its growth financing round, a significant milestone in the company’s mission to decarbonize the wastewater sector. The financing round, led by Nordic Alpha Partners (NAP), also includes investments from the European Innovation Council ...

mediaire transforms radiology with AI

Start-up securing a European €12 million investment to fuel global growth

14-Nov-2024 - While Generative AI is creating a buzz across industries and remains in the early stages of the hype cycle, AI in radiology is no longer just a vision for the future. mediaire’s proven AI value is already happening in over 350 hospitals and clinics across Europe, where the German radiology ...

Aignostics secures $34 million Series B to improve precision medicine with AI

Investments will support new product offerings, US expansion, and development of pathology foundation models

05-Nov-2024 - Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, ...

Variolytics receives seven-figure seed funding for climate-neutral wastewater treatment plants

Proprietary measurement technology and AI-based process control to avoid greenhouse gases in wastewater treatment

13-Dec-2022 - Germany’s almost 10,000 municipal wastewater treatment plants consume around 4,400 gigawatt hours (GWh) of electricity per year, which makes them one of the largest electricity consumers. This is equivalent to the electricity needs of 900,000 four-person households. Moreover, the greenhouse gases ...

Aignostics Raises €14m Series A to Advance AI-powered Pathology

Spin-off from Charité developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases

19-Sep-2022 - Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, today announced the closing of an oversubscribed €14m Series A financing round. Wellington Partners led the round, ...

Deep learning for faster, more accurate and safer MRI analysis

International pool invests ~ 2 Mio € in medicine start-up mediaire

17-Dec-2020 - HTGF, primeCROWD and LIFTT are part of an international round for the development of “Deep learning diagnostic” which allows faster, more accurate and safer MRI analysis. Expansion into European markets will start in 2021 accompanied by a significant expansion of product portfolio mediaire, the ...

Spin-off from Charité want to advance AI-powered pathology

Aignostics Raises €5 Million Seed Round

31-Aug-2020 - Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering computational pathology for pharmaceutical research and diagnostics, has announced the closing of a €5 M seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the round, ...

Artificial Intelligence for faster and more reliable radiological findings

11-Apr-2019 - The use of Artificial Intelligence makes medical findings faster and more reliable: mediaire GmbH is developing innovative methods that help radiologists detect neurodegenerative diseases, such as Alzheimer’s or Multiple Sclerosis, earlier and faster. The High-Tech Gründerfonds (HTGF), together ...